Evaluating the Impact of InSee on Incentive Spirometer Utilization

Overview

About this study

The purpose of this study is to determine if the frequency of patients’ use of physician ordered incentive spirometry increases with visual and auditory electronic reminders and encouragement compared to the no signal cohort.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient has undergone a qualifying surgical procedure.
  • Patient is aged 18 years or over.
  • Patient has incentive spirometry ordered or incentive spirometry must be part of the study site’s standard of care which is implemented by hospital staff.
  • Patient is able to comply with all study required incentive spirometry instructions.
  • Patient is without severe hearing or impaired visual acuity deficiency such that they cannot hear or see the audible and visual signal for the InSee monitor.

Exclusion Criteria:

  • Vulnerable Populations (pregnant, minors, prisoners, those with significantly reduced mental acuity).
  • Patients where incentive spirometry is inappropriate (patients with Tracheostomy, patients who are hemodynamically unstable defined as Vasoactive-Inotropic Score Plus (VIS+) greater than or equal to 20, patients in airborne or droplet precaution).
  • Patients with a history of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction), delirium, or cognitive issue which would in the opinion of the investigator, make it difficult for the patient to comply with the study procedures or follow the investigators instructions.
  • Any medical condition that, in the opinion of the investigator, would place the patient at increased risk if they participated.
  •  Any physician determination that the patient should not participate.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 5/8/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

William LeTourneau, R.R.T., L.R.T.

Open for enrollment

Contact information:

Nicole Lenort R.R.T., L.R.T.

(507) 293-2535

Lenort.Nicole@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20571391

Mayo Clinic Footer